Join to View Full Profile
Usc Keck School Of Medicine2011 Zonal Avenue, Hmr 205Los Angeles, CA 90089
Phone+1 818-426-9595
Fax+1 323-442-3049
Dr. Epstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Pathology-Anatomic and Clinical, 1984 - 1985
Stanford University School of MedicineClass of 1978
Certifications & Licensure
CA State Medical License 1985 - 2025
Publications & Presentations
PubMed
- 1 citationsEnhancing brain entry and therapeutic activity of chimeric antigen receptor T cells with intra-arterial NEO100 in a mouse model of CNS lymphoma.Weijun Wang, Haiping He, Long Zheng, Shan Zeng, Hee-Yeon Cho
Journal of Neurosurgery. 2024-06-01 - 4 citationsImmune Priming with Spatially Fractionated Radiation Therapy.Lauren Lukas, Hualin Zhang, Karen Cheng, Alan Epstein
Current Oncology Reports. 2023-12-01 - 2 citationsEnhanced brain entry of checkpoint-inhibitory therapeutic antibodies facilitated by intraarterial NEO100 in mouse models of brain-localized malignancies.Weijun Wang, Haiping He, Shan Zeng, Hee-Yeon Cho, Radu O Minea
Journal of Neurosurgery. 2023-09-01
Press Mentions
Congress of Clinical Rheumatology Reloaded: West Follows East with Fresh Topics, SpeakersAugust 27th, 2021
Grant Support
- Monoclonal Antibodies Against T-Regulatory CellsNational Cancer Institute2004–2005
- TNT Imaging To Monitor The Efficacy Of Cancer TherapyNational Cancer Institute2000–2002
- Immunotherapy Of Lymphomas With Lym-1 And Lym-2National Cancer Institute1994
- Immunotherapy Of Human Lymphomas With Lym-1 And Lym-2National Cancer Institute1992–1993
- Tumor Necrosis Treatment Of Human CancerNational Cancer Institute1991–1993
- Immunotherapy Of Human Lymphomas W/Lym-1 &Lym-2National Cancer Institute1988–1990
- Development And Characterization Of Myeloma Cell LinesNational Cancer Institute1985–1987
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
